Promising, but still a matter of debate

Yohei Sotomi; Patrick W. Serruys

doi:10.1002/ccd.26729

Promising, but still a matter of debate

Yohei Sotomi, Patrick W. Serruys

Research output: Contribution to a Journal (Peer & Non Peer) › Editorial

1 Citation (Scopus)

Abstract

Several trials failed to demonstrate the efficacy of plaque modification device in patients with severely calcified coronary lesions. Safety and efficacy of the Diamondback 360® Coronary OAS have been demonstrated by the ORBIT II trial. The 2-year follow-up of the ORBIT II trial extends the favorable results previously shown at 30-day and 1-year follow-up. The single arm, non-randomized character of the trial with indirect historical comparison may restrict the results to hypothesis generating and entail further prospective randomized trials.

Original language	English
Pages (from-to)	378-379
Number of pages	2
Journal	Catheterization and Cardiovascular Interventions
Volume	88
Issue number	3
DOIs	https://doi.org/10.1002/ccd.26729
Publication status	Published - 1 Sep 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ccd.26729

Cite this

@article{666ae32d0ab84ab5b6096a0c307d6ec0,

title = "Promising, but still a matter of debate",

abstract = "Several trials failed to demonstrate the efficacy of plaque modification device in patients with severely calcified coronary lesions. Safety and efficacy of the Diamondback 360{\textregistered} Coronary OAS have been demonstrated by the ORBIT II trial. The 2-year follow-up of the ORBIT II trial extends the favorable results previously shown at 30-day and 1-year follow-up. The single arm, non-randomized character of the trial with indirect historical comparison may restrict the results to hypothesis generating and entail further prospective randomized trials.",

author = "Yohei Sotomi and Serruys, {Patrick W.}",

note = "Publisher Copyright: {\textcopyright} 2016 Wiley Periodicals, Inc.",

year = "2016",

month = sep,

day = "1",

doi = "10.1002/ccd.26729",

language = "English",

volume = "88",

pages = "378--379",

journal = "Catheterization and Cardiovascular Interventions",

issn = "1522-1946",

number = "3",

}

TY - JOUR

T1 - Promising, but still a matter of debate

AU - Sotomi, Yohei

AU - Serruys, Patrick W.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Several trials failed to demonstrate the efficacy of plaque modification device in patients with severely calcified coronary lesions. Safety and efficacy of the Diamondback 360® Coronary OAS have been demonstrated by the ORBIT II trial. The 2-year follow-up of the ORBIT II trial extends the favorable results previously shown at 30-day and 1-year follow-up. The single arm, non-randomized character of the trial with indirect historical comparison may restrict the results to hypothesis generating and entail further prospective randomized trials.

AB - Several trials failed to demonstrate the efficacy of plaque modification device in patients with severely calcified coronary lesions. Safety and efficacy of the Diamondback 360® Coronary OAS have been demonstrated by the ORBIT II trial. The 2-year follow-up of the ORBIT II trial extends the favorable results previously shown at 30-day and 1-year follow-up. The single arm, non-randomized character of the trial with indirect historical comparison may restrict the results to hypothesis generating and entail further prospective randomized trials.

UR - http://www.scopus.com/inward/record.url?scp=84986879573&partnerID=8YFLogxK

U2 - 10.1002/ccd.26729

DO - 10.1002/ccd.26729

M3 - Editorial

C2 - 27619745

AN - SCOPUS:84986879573

SN - 1522-1946

VL - 88

SP - 378

EP - 379

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

IS - 3

ER -

Promising, but still a matter of debate

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this